How Allergy Drops Work: Why Under-the-Tongue Changes Your Immune System

Quick Answer

Under your tongue sits a cluster of immune cells biased toward tolerance, not attack. These tolerogenic dendritic cells capture allergen from drops and teach your immune system to ignore it — shifting from allergic (TH2) to tolerant (TH1/Treg) mode. No allergen enters your bloodstream while drops are held under the tongue — the FDA states "Human Pharmacokinetics: Not applicable" (Bagnasco 1997/2005). Common misconception corrected: sublingual tissue does NOT have the highest Langerhans cell density; it has the most tolerogenic phenotype (Allam 2008).

Quick Facts

Detail	Info
Why under-tongue works	Tolerogenic dendritic cell phenotype — NOT highest cell count (Allam 2008)
Immune shift	TH2 (allergic) → TH1/Treg (tolerant)
Blocking antibodies	IgG4 detectable 4–8 weeks; peaks ~22–24 months
Systemic absorption	None while held sublingual — FDA: "PK not applicable"
SLIT dose vs SCIT dose	50–100× higher cumulative allergen, limited by mucosal barrier
Monthly cost of allergy drops	$39–99/month depending on insurance (2026)

"How Can a Few Drops Under My Tongue Actually Fix My Allergies?"

It sounds almost too simple. Put drops under your tongue. Hold for 2 minutes. Swallow. Repeat every morning. And somehow, over months, your immune system — which has been attacking cat dander, dust mites, or pollen for years — just... stops?

The skepticism is reasonable. Allergy shots inject allergen into muscle with a needle. That seems like it's doing something. Drops under the tongue feel like nothing is happening. Your tongue doesn't swell. You don't feel different. Where's the proof that anything went in?

Understanding the mechanism doesn't just satisfy curiosity — it explains why drops are safe enough for home use, why they require 50–100× more allergen than shots, and why they take 3–5 years to produce lasting change.

The Three-Step Immune Retraining Process

Step 1 — Tolerogenic dendritic cells capture the allergen. The sublingual mucosa contains specialized dendritic cells with a unique tolerogenic phenotype — they express B7-H1, B7-H3, and B7-DC (tolerance signals) plus high-affinity IgE receptors (FcεRI) (Allam 2008). Common marketing claim corrected: sublingual tissue does NOT have the highest Langerhans cell density — the vestibular region is actually higher. What makes the sublingual site optimal is the tolerance-biased signaling, not the cell count. About 40% of sublingual Langerhans cells bind allergen in a dose-dependent manner, and this binding attenuates their maturation toward pro-inflammatory activity, instead upregulating TGF-β1 and IL-10 (Allam 2010, JACI).

Step 2 — The tissue itself is structured for safety. Sublingual tissue contains very few mast cells or eosinophils — the cells that drive allergic reactions. These are sequestered in deeper submucosal layers (Moingeon & Mascarell 2012). Allergen reaches tolerogenic dendritic cells before encountering pro-inflammatory cells. This is why drops are dramatically safer than shots: the allergen contacts tolerance-promoting cells first, in a tissue that lacks the inflammatory machinery to produce systemic reactions.

Step 3 — Your immune system shifts from attack to tolerance. The tolerogenic DCs migrate to cervical lymph nodes and reprogram T cells from TH2 (allergic) to TH1/Treg (tolerant). IgE spikes ~10-fold at month 1, then progressively declines. By 2 years post-treatment, 67% maintain IgE below pre-treatment levels (Suárez-Fueyo 2018). IgG4 blocking antibodies appear at 4–8 weeks, peak at ~22–24 months (~23-fold above baseline per Scaparrotta 2015), and functionally block allergen from binding to IgE.

Why Drops Require 50–100× More Allergen Than Shots

SLIT requires 50–100× higher cumulative allergen doses than SCIT for comparable efficacy. The reason: the sublingual mucosal barrier limits systemic absorption. No circulating radioactivity was detected while radiolabeled allergen was held under the tongue — the allergen persists in the mucosa for 18–20 hours (Bagnasco 1997/2005). This is fundamentally different from injection, which delivers allergen directly into systemic circulation.

This also explains why natural allergen exposure doesn't produce tolerance: natural inhalation delivers nanograms intermittently through damaged epithelium with alarm signals (TSLP, IL-33, IL-25). SLIT delivers micrograms daily through intact tolerogenic epithelium. Same allergen, completely different immune context.

When Understanding the Mechanism Reveals a Limitation

Drops retrain your adaptive immune system — they do NOT treat non-allergic rhinitis (vasomotor rhinitis). If allergy testing shows you're NOT sensitized to common allergens but you still have chronic congestion, immunotherapy won't help.

About 23% of chronic rhinitis patients have pure non-allergic rhinitis, and 34% have mixed allergic/non-allergic (Settipane 2001). That means approximately 57% of chronic rhinitis has some non-allergic component. If you've been on drops for 6+ months with zero improvement despite confirmed allergic sensitization, investigate whether a non-allergic component is the real driver.

Additionally, drops produce 10–30× less IgG4 than shots — but compensate through mucosal IgA and distinct T-regulatory pathways. Functional allergen blocking converges between modalities (Shamji 2021, JACI). The mechanism works differently; the clinical endpoint is the same.

Related Issues to Check

• How long until allergy drops work? — The biological timeline maps directly to the mechanism: IgG4 at 4–8 weeks, clinical improvement at 3–6 months, IgG4 peak at 22–24 months. The month-by-month guide connects immune changes to symptom changes.

• Allergy drops at home: safety — The safety profile (zero fatalities across 1+ billion doses) is a direct consequence of the sublingual tissue's low mast cell density and mucosal barrier. The mechanism explains the safety.

• Allergy drops vs allergy shots — Both modalities converge on the same immune endpoint through different pathways. Understanding the mechanism helps explain why shots produce more IgG4 but drops compensate through mucosal immunity — and why clinical outcomes are comparable.

Frequently Asked Questions

Does allergen from drops enter my bloodstream? No. Radiolabeled allergen studies (Bagnasco 1997/2005) detected no circulating radioactivity while allergen was held under the tongue. The FDA states: "Human Pharmacokinetics: Not applicable." Allergen persists in the sublingual mucosa for 18–20 hours, interacting locally with immune cells.

Why can't I just eat the allergen to build tolerance? Gastric acid destroys allergen proteins. Sublingual tissue holds the allergen against immune cells for absorption before swallowing. The 2-minute hold time isn't arbitrary — it allows allergen to bind to 40% of local Langerhans cells (Allam 2010).

If drops produce less IgG4, are they weaker than shots? SCIT produces 10–30× more IgG4. But SLIT compensates with mucosal IgA and different T-regulatory pathways. Functional allergen blocking converges (Shamji 2021, JACI). Multiple meta-analyses confirm no significant clinical difference for standardized products.

Why does IgE spike in the first month of treatment? The initial allergen introduction stimulates existing IgE-producing B cells before the tolerogenic pathway suppresses them. This is expected and temporary. By 2 years post-treatment, 67% maintain IgE below pre-treatment levels (Suárez-Fueyo 2018).

Is the sublingual route unique to immunotherapy? No — nitroglycerin, buprenorphine, and several other medications use sublingual delivery for rapid absorption without first-pass metabolism. But SLIT is unique in exploiting the sublingual tissue's tolerogenic immune environment rather than just its absorptive properties.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Take the Next Step

If understanding how drops work has answered your mechanism questions, a 3-minute allergy quiz identifies whether immunotherapy is right for your specific triggers and severity.

Take the free 3-minute allergy quiz →